Key Takeaways
- CrowdStrike boosted its share repurchase authorization by $500M, increasing the total program to $1.5 billion.
- CRWD began Monday’s session at $399.12 with approximately $101.2 billion in market capitalization.
- Morgan Stanley elevated CRWD to Overweight with a $510 price objective; consensus analyst target reaches ~$505.
- Institutional ownership accounts for 71.16% of shares; company insiders divested approximately 68,636 shares valued at $28.7M over three months.
- Fourth quarter revenue reached $1.31B, representing 23.8% year-over-year growth and surpassing projections by roughly $10M.
CrowdStrike (CRWD) kicked off Monday’s trading at $399.12, substantially beneath its 52-week peak of $566.90.
CrowdStrike Holdings, Inc., CRWD
The cybersecurity company revealed on Monday that it’s enlarging its share buyback initiative by $500 million, elevating total authorization to $1.5 billion. CrowdStrike has previously repurchased 413,130 Class A shares at a weighted average cost of $364.57, representing $150.6 million in aggregate spending under the current program.
Chief Financial Officer Burt Podbere connected the decision to the firm’s strategic objective of achieving $20 billion in annual recurring revenue by fiscal 2036. “We have expanded our share repurchase authorization to $1.5 billion to opportunistically deliver value to shareholders,” Podbere stated.
This disclosure arrives as CRWD exchanges hands approximately 30% beneath its 52-week peak, a decline partially attributed to industry-wide pressure following speculation that sophisticated AI technologies might supplant certain security capabilities.
The equity’s 50-day simple moving average rests at $411.92, whereas the 200-day moving average stands at $467.32 — both positioned above the stock’s present trading level.
Wall Street Maintains Generally Optimistic Outlook
Professional analyst coverage continues to lean favorable. Morgan Stanley elevated CRWD from equal weight to overweight during March, increasing its price objective from $487 to $510. Truist maintains a buy designation with a $550 forecast, while Daiwa holds an outperform rating alongside a $500 projection. The consensus analyst price objective hovers around $504.98, with an overall “Moderate Buy” recommendation from 51 Wall Street analysts.
The rating breakdown includes one strong buy recommendation, 34 buy ratings, 15 hold designations, and a single sell rating.
Runnymede Capital Advisors established a fresh stake during Q4, acquiring 3,160 shares valued at approximately $1.48 million. Multiple institutional investors have similarly expanded their holdings in recent reporting periods, including Carnegie Investment Counsel and Traynor Capital Management.
Zacks Research elevated CRWD from strong sell to hold during March, and the enterprise exceeded fourth quarter profit forecasts — delivering $1.12 earnings per share versus the $1.10 consensus, alongside revenue of $1.31 billion compared to anticipated $1.30 billion.
Executive Share Dispositions Persist
Conversely, insider transactions have shown consistent selling activity. Chief Executive Officer George Kurtz divested 28,853 shares during early February at an average of $413.01, generating approximately $11.9 million. This transaction decreased his stake by 1.38%, leaving him with roughly 2.05 million shares.
President Michael Sentonas disposed of 19,367 shares in late March at $411.06, amounting to approximately $7.96 million. Collectively, company insiders have sold around 68,636 shares worth $28.7 million during the previous 90-day period. Executive ownership currently represents about 3.32% of the corporation.
CrowdStrike has additionally broadened its GovCloud platform and introduced a CTEM service through partnership with HCLTech, both initiatives designed to expand its enterprise and government sector client portfolio.
The security software provider has a 52-week trading range spanning from $298.00 to $566.90. Wall Street analysts project earnings per share of $0.55 for the ongoing fiscal year.
